Integrated Proteins Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	99.36	214.96	2.37	1.67	-
Other Revenue	-	-0	-	-	-
Revenue	99.36	214.96	2.37	1.67	-
Revenue Growth (YoY)	-53.78%	8954.84%	42.16%	-	-
Cost of Revenue	95.01	210.25	2.22	1.47	-
Gross Profit	4.34	4.71	0.15	0.2	-
Selling, General & Admin	0.32	0.21	0.62	0.04	0.14
Other Operating Expenses	1.24	3.5	0.71	1.01	0.64
Operating Expenses	1.56	3.8	1.6	1.34	1.06
Operating Income	2.78	0.91	-1.45	-1.14	-1.06
Interest Expense	-	-	-	-	-0
Interest & Investment Income	-	1.53	1.56	1.56	1.56
Other Non Operating Income (Expenses)	0.05	-	-0	-0	0
EBT Excluding Unusual Items	2.83	2.44	0.11	0.42	0.49
Gain (Loss) on Sale of Assets	-	0.75	0.93	-	-
Pretax Income	2.83	3.19	1.04	0.42	0.49
Income Tax Expense	0.58	0.69	0.15	0.11	0.13
Net Income	2.25	2.5	0.89	0.31	0.37
Net Income to Common	2.25	2.5	0.89	0.31	0.37
Net Income Growth	-10.00%	179.95%	189.00%	-15.34%	72.17%
Shares Outstanding (Basic)	19	4	3	3	3
Shares Outstanding (Diluted)	19	4	3	3	3
Shares Change (YoY)	432.64%	9.88%	-	-	-0.01%
EPS (Basic)	0.12	0.71	0.28	0.10	0.11
EPS (Diluted)	0.12	0.71	0.25	0.09	0.11
EPS Growth	-83.10%	184.00%	177.78%	-21.01%	72.19%
Gross Margin	4.37%	2.19%	6.36%	11.98%	-
Operating Margin	2.80%	0.43%	-60.91%	-68.08%	-
Profit Margin	2.27%	1.16%	37.62%	18.50%	-
EBITDA	2.88	1.01	-1.18	-0.85	-0.77
EBITDA Margin	2.90%	0.47%	-49.79%	-50.84%	-
D&A For EBITDA	0.1	0.1	0.26	0.29	0.29
EBIT	2.78	0.91	-1.45	-1.14	-1.06
EBIT Margin	2.80%	0.43%	-60.91%	-68.08%	-
Effective Tax Rate	20.58%	21.73%	14.05%	26.08%	26.11%
Revenue as Reported	99.41	217.34	4.86	3.23	1.56
Advertising Expenses	-	0.05	0.01	0.01	0.01